Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VCKA

Vickers Vantage Corp. I (VCKA) Stock Price, News & Analysis

About Vickers Vantage Corp. I Stock (NASDAQ:VCKA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$8.77
$10.50
52-Week Range
N/A
Volume
1,404 shs
Average Volume
36,105 shs
Market Capitalization
$118.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

As of November 10, 2022, Vickers Vantage Corp. I was acquired by Scilex Holding Company, in a reverse merger transaction. Vickers Vantage Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Singapore.

Receive VCKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vickers Vantage Corp. I and its competitors with MarketBeat's FREE daily newsletter.

VCKA Stock News Headlines

Murder charges against teen's mother dropped
Realty Income Corp O
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Clover Corp.
Vickers Vantage Corp. I Warrant
KDKGF - Klondike Gold Corp.
8-K: Lifevantage Corp
Vickers Vantage Corp I (VCKAU)
See More Headlines

VCKA Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Vickers Vantage Corp. I investors own include T. Rowe Price Group (TROW) and Intuitive Surgical (ISRG).

Company Calendar

Today
6/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:VCKA
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$780 thousand
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
374.61
Book Value
($0.91) per share
Price / Book
N/A

Miscellaneous

Free Float
10,541,000
Market Cap
$118.72 million
Optionable
Not Optionable
Beta
0.03
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:VCKA) was last updated on 6/29/2025 by MarketBeat.com Staff
From Our Partners